First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress
source: pixabay.com

First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress

Idiopathic Pulmonary Fibrosis Progression Veracyte has just signed a deal with Yale University which will help them develop the very first test which can predict disease progression for idiopathic pulmonary…

Continue Reading First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress
A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
source: pixabay.com

A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!

Edwin Chapman, who works at the University of Wisconsin-Madison, has been studying neurons for most of his career. He and his team recently made a discovery regarding SYT1-associated neurodevelopmental disorder.…

Continue Reading A Multiple Sclerosis Treatment May Aid SYT1-Associated Neurodevelopmental Disorder Patients Too!
Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
source: pixabay.com

Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic

By Natalie Homan from In The Cloud Copy Two businesses that advocate for patients with rare and orphan diseases announced recently that they are teaming up to help patients get…

Continue Reading Industry Leaders Team Up to Advocate for Rare Disease Patients Despite the COVID-19 Pandemic
Lupus Nephritis Biomarkers Highlight Race-Based Differences
https://pixabay.com/en/hand-united-together-people-unity-1917895/

Lupus Nephritis Biomarkers Highlight Race-Based Differences

When studying biomarkers of lupus nephritis, researchers at the University of Houston discovered something interesting: race-based differences. Biomarkers are some sort of measurable substance; in this case, urinary proteins. However,…

Continue Reading Lupus Nephritis Biomarkers Highlight Race-Based Differences
Early Treatment of Juvenile Idiopathic Arthritis Improves Outcomes, Inactivates Disorder
IAOM-US / Pixabay

Early Treatment of Juvenile Idiopathic Arthritis Improves Outcomes, Inactivates Disorder

According to Juvenile Arthritis News, treating juvenile idiopathic arthritis early helps reduce symptoms, nearly "inactivating" the condition. The Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) JIA Registry found that early…

Continue Reading Early Treatment of Juvenile Idiopathic Arthritis Improves Outcomes, Inactivates Disorder
Researchers Discover Method to Predict Survival in Low-Risk Myelodysplastic Syndromes
source: pixabay.com

Researchers Discover Method to Predict Survival in Low-Risk Myelodysplastic Syndromes

A recent study published in Blood Cancer Journal has established a new method for effectively predicting survival outcomes for patients with low-risk myelodysplastic syndromes (MDS). The method is known as the…

Continue Reading Researchers Discover Method to Predict Survival in Low-Risk Myelodysplastic Syndromes